Literature DB >> 1507006

Update on inborn errors of metabolism: primary lactic acidemia.

G R Goldberg, C L Greene.   

Abstract

Initially thought to be rare, primary lactic acidemia is diagnosed with increasing frequency. Elevations in lactate and pyruvate are markers for a variety of metabolic blocks. Although there have been great strides made in the diagnosis and treatment of lactic acidemia, much remains to be learned. As laboratory techniques improve, clinicians will be able to make an exact enzymatic diagnosis on an increasing percentage of patients. Specific enzymatic diagnosis also will help clinicians determine inheritance patterns, recurrence risks, and methods of prenatal diagnosis.

Entities:  

Mesh:

Year:  1992        PMID: 1507006     DOI: 10.1016/0891-5245(92)90002-l

Source DB:  PubMed          Journal:  J Pediatr Health Care        ISSN: 0891-5245            Impact factor:   1.812


  3 in total

1.  Metabolite Signatures of Metabolic Risk Factors and their Longitudinal Changes.

Authors:  Xiaoyan Yin; Subha Subramanian; Christine M Willinger; George Chen; Peter Juhasz; Paul Courchesne; Brian H Chen; Xiaohang Li; Shih-Jen Hwang; Caroline S Fox; Christopher J O'Donnell; Pieter Muntendam; Valentin Fuster; Ivana Bobeldijk-Pastorova; Silvia C Sookoian; Carlos J Pirola; Neal Gordon; Aram Adourian; Martin G Larson; Daniel Levy
Journal:  J Clin Endocrinol Metab       Date:  2016-02-23       Impact factor: 5.958

Review 2.  Etiology and therapeutic approach to elevated lactate levels.

Authors:  Lars W Andersen; Julie Mackenhauer; Jonathan C Roberts; Katherine M Berg; Michael N Cocchi; Michael W Donnino
Journal:  Mayo Clin Proc       Date:  2013-10       Impact factor: 7.616

Review 3.  Comparison Between Dichloroacetate and Phenylbutyrate Treatment for Pyruvate Dehydrogenase Deficiency.

Authors:  Patricia Karissa; Timothy Simpson; Simon P Dawson; Teck Yew Low; Sook Hui Tay; Fatimah Diana Amin Nordin; Shamsul Mohd Zain; Pey Yee Lee; Yuh-Fen Pung
Journal:  Br J Biomed Sci       Date:  2022-05-19       Impact factor: 2.432

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.